We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Ubiquiti
UI
$34.6B
| $1.68M | ﹤0.01% |
5,759
-705
| -11% | -$190K |
|
1902
Ingles Markets
IMKTA
$1.65B
| $1.68M | ﹤0.01% |
18,808
-1,267
| -6% | -$108K |
|
|
SRDX
1903
DELISTED
Surmodics
SRDX
| $1.67M | ﹤0.01% |
36,826
+1,581
| +4% | +$69.2K |
|
1904
Winmark
WINA
$1.32B
| $1.67M | ﹤0.01% |
7,581
-2,918
| -28% | -$657K |
|
1905
Playtika
PLTK
$1.07B
| $1.67M | ﹤0.01% |
86,165
-7,138
| -8% | -$127K |
|
1906
Vir Biotechnology
VIR
$1.5B
| $1.67M | ﹤0.01% |
64,769
+915
| +1% | +$27.1K |
|
|
UHT
1907
Universal Health Realty Income Trust
UHT
$574M
| $1.66M | ﹤0.01% |
28,488
-5,200
| -15% | -$301K |
|
1908
Tootsie Roll Industries
TR
$2.98B
| $1.66M | ﹤0.01% |
53,381
+1,711
| +3% | +$51.1K |
|
|
AIV
1909
Aimco
AIV
$377M
| $1.65M | ﹤0.01% |
225,447
-889
| -0.4% | -$6.33K |
|
|
INFN
1910
DELISTED
Infinera Corporation Common Stock
INFN
| $1.65M | ﹤0.01% |
189,711
-3,262
| -2% | -$28K |
|
1911
Par Pacific Holdings
PARR
$3.63B
| $1.64M | ﹤0.01% |
126,220
+11,201
| +10% | +$160K |
|
1912
PJT Partners
PJT
$4.26B
| $1.64M | ﹤0.01% |
25,944
-1,846
| -7% | -$120K |
|
|
EGRX
1913
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.64M | ﹤0.01% |
33,027
+885
| +3% | +$42.5K |
|
|
CVGW
1914
DELISTED
Calavo Growers
CVGW
| $1.63M | ﹤0.01% |
44,741
+1,982
| +5% | +$80.8K |
|
1915
Stock Yards Bancorp
SYBT
$2.57B
| $1.62M | ﹤0.01% |
30,672
-2,398
| -7% | -$137K |
|
1916
Virgin Galactic
SPCE
$404M
| $1.62M | ﹤0.01% |
8,205
+12
| +0.1% | +$2.24K |
|
1917
American Vanguard Corp
AVD
$68.1M
| $1.62M | ﹤0.01% |
79,686
-264
| -0.3% | -$4.32K |
|
1918
OptimizeRx
OPRX
$128M
| $1.62M | ﹤0.01% |
42,886
+4,878
| +13% | +$216K |
|
|
FBRT
1919
Franklin BSP Realty Trust
FBRT
$641M
| $1.61M | ﹤0.01% |
115,385
+1,159
| +1% | +$15.8K |
|
1920
Clear Channel Outdoor Holdings
CCO
$1.23B
| $1.6M | ﹤0.01% |
463,891
-2,806
| -0.6% | -$9.53K |
|
1921
Kearny Financial
KRNY
$595M
| $1.6M | ﹤0.01% |
124,510
-37,659
| -23% | -$499K |
|
|
TPTX
1922
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.6M | ﹤0.01% |
59,510
-4,644
| -7% | -$156K |
|
1923
REX American Resources
REX
$1.43B
| $1.6M | ﹤0.01% |
96,162
-408
| -0.4% | -$6.6K |
|
1924
Schrodinger
SDGR
$1.39B
| $1.59M | ﹤0.01% |
46,592
+1,141
| +3% | +$34.7K |
|
1925
Krystal Biotech
KRYS
$9.64B
| $1.59M | ﹤0.01% |
23,839
+2,172
| +10% | +$136K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.